BioCorRx Inc.: total liabilities
Total liabilities for BioCorRx Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BioCorRx Inc. financial histories
What this measure means
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
Exact concept: us-gaap:Liabilities. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 13,674,200 | USD | 2026-03-31 | 10-K · 0001477932-26-001807 |
| At date | 2024-12-31 | 12,741,173 | USD | 2026-03-31 | 10-K · 0001477932-26-001807 |
| At date | 2023-12-31 | 10,341,411 | USD | 2025-03-31 | 10-K · 0001477932-25-002219 |
| At date | 2022-12-31 | 8,968,325 | USD | 2024-04-01 | 10-K · 0001477932-24-001705 |
| At date | 2021-12-31 | 7,781,451 | USD | 2023-03-31 | 10-K · 0001477932-23-002039 |
| At date | 2020-12-31 | 6,037,353 | USD | 2022-03-31 | 10-K · 0001477932-22-001817 |
| At date | 2019-12-31 | 4,992,128 | USD | 2021-03-31 | 10-K · 0001477932-21-001909 |
| At date | 2018-12-31 | 6,334,589 | USD | 2020-03-30 | 10-K · 0001477932-20-001621 |
| At date | 2017-12-31 | 4,231,835 | USD | 2019-04-16 | 10-K · 0001477932-19-001764 |
| At date | 2016-12-31 | 8,600,710 | USD | 2018-04-05 | 10-K · 0001477932-18-001699 |
| At date | 2015-12-31 | 4,688,074 | USD | 2017-04-13 | 10-K · 0001477932-17-001708 |
| At date | 2014-12-31 | 3,776,920 | USD | 2016-04-14 | 10-K · 0001477932-16-009752 |
| At date | 2013-12-31 | 4,203,070 | USD | 2015-03-31 | 10-K · 0001477932-15-002108 |
| At date | 2012-12-31 | 2,246,130 | USD | 2014-04-14 | 10-K · 0001477932-14-001677 |
| At date | 2011-12-31 | 1,024,309 | USD | 2012-05-18 | 10-K · 0001494733-12-000091 |
| At date | 2010-12-31 | 184,636 | USD | 2012-05-18 | 10-K · 0001494733-12-000091 |
Related financial histories
- BioCorRx Inc.: total assets
- BioCorRx Inc.: stockholders equity
- BioCorRx Inc.: cash and cash equivalents
- BioCorRx Inc.: net income or loss
- BioCorRx Inc.: operating cash flow
- BioCorRx Inc.: capital expenditure payments
- BioCorRx Inc.: revenue
- BioCorRx Inc.: financing cash flow
- BioCorRx Inc.: investing cash flow
- BioCorRx Inc.: retained earnings or deficit
- BioCorRx Inc.: basic weighted-average shares
- BioCorRx Inc.: diluted weighted-average shares
- BioCorRx Inc.: income tax expense or benefit
- BioCorRx Inc.: net property, plant and equipment
- BioCorRx Inc.: share-based compensation expense
- BioCorRx Inc.: operating income or loss
- BioCorRx Inc.: current assets
- BioCorRx Inc.: interest expense
- BioCorRx Inc.: current liabilities
- BioCorRx Inc.: current accounts payable
- BioCorRx Inc.: net finite-lived intangible assets
- BioCorRx Inc.: net current accounts receivable
- BioCorRx Inc.: operating expenses
- BioCorRx Inc.: gross profit
- BioCorRx Inc.: cost of revenue
- BioCorRx Inc.: selling, general and administrative expense
- BioCorRx Inc.: research and development expense
Inspect the source
- Entity
- BioCorRx Inc. / CIK 0001443863
- Captured
- 2026-09-20T09:04:22.712Z
- SEC response SHA-256
ac5d4257d7a196e773d03095d841b6e99a8b7a937efc54ce0410975e44478703
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001443863.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))